North America Ophthalmic Drug Delivery System Market to Reach $12.8 Billion by 2031 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "North America Ophthalmic Drug Delivery System Market 2021-2031 by Product, Dosage Form, Disease, Setting, and Country: Trend Forecast and Growth Opportunity" report has been added to ResearchAndMarkets.com's offering.

North America ophthalmic drug delivery system market is projected to grow by 6.1% annually in the forecast period and reach $12,809.8 million by 2031, driven by the growing prevalence of ophthalmic diseases, the emerging novel ocular drug delivery systems, rise in number of ophthalmic procedures that require attentive post procedural care, and the increasing demand to deliver controlled dosage forms for pediatric and geriatric population.

In-depth qualitative analyses include identification and investigation of the following aspects:

• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter's Fiver Forces

Based on Product, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

• Pre-filled Syringes
• Multidose Eyedroppers
• Squeeze Dispensers
• Mist Sprayers
• Contact Lenses
• Ocular Inserts
• Intraocular Implants
• Punctal Plugs
• Other Products

Based on Dosage Form, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

• Solutions
• Gels
• Ointments
• Suspensions
• Emulsions
• Liposomes & Nanoparticles

By Disease, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

• Glaucoma
• Diabetic Retinopathy
• Cataract
• Dry Eye Syndrome
• Macular Degeneration
• Diabetic Macular Edema
• Refractive Issues
• Other Diseases

By Setting, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

• Hospitals
• Clinics
• Homecare Settings
• Ambulatory Surgical Centers (ASCs)
• Other Settings

Geographically, the following national/local markets are fully investigated:

• U.S.
• Canada
• Mexico

For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Product, Dosage Form, and Setting over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Selected Key Players

• Aero Pump GmbH
• Allergan plc.
• AptarGroup, Inc.
• Becton, Dickinson and Company
• Biocorp
• Clearside Biomedical, Inc.
• EyePoint Pharmaceuticals, Inc.
• Gaplast GmbH
• Gerresheimer AG
• Jotteq Inc.
• Kedalion Therapeutics, Inc.
• Mati Therapeutics, Inc.
• Nemera
• Nipro Corporation
• Ocular Therapeutix, Inc.
• Ocumedic, Inc.
• Owen Mumford
• Re-Vana Therapeutics
• Silgan Holdings Inc.
• Terumo Corporation
• Valeant Pharmaceuticals International Inc. (Bausch Health Company)
• West Pharmaceutical Services, Inc.

Key Topics Covered:

1 Introduction

2 Market Overview and Dynamics

2.1 Market Size and Forecast

2.1.1 Impact of COVID-19 on World Economy

2.1.2 Impact of COVID-19 on the Market

2.2 Major Growth Drivers

2.3 Market Restraints and Challenges

2.4 Emerging Opportunities and Market Trends

2.5 Porter's Fiver Forces Analysis

3 Segmentation of North America Market by Product

3.1 Market Overview by Product

3.2 Pre-filled Syringes

3.3 Multidose Eyedroppers

3.4 Squeeze Dispensers

3.5 Mist Sprayers

3.6 Contact Lenses

3.7 Ocular Inserts

3.8 Intraocular Implants

3.9 Punctal Plugs

3.10 Other Products

4 Segmentation of North America Market by Dosage Form

4.1 Market Overview by Dosage Form

4.2 Solutions

4.3 Gels

4.4 Ointments

4.5 Suspensions

4.6 Emulsions

4.7 Liposomes & Nanoparticles

5 Segmentation of North America Market by Disease

5.1 Market Overview by Disease

5.2 Glaucoma

5.3 Diabetic Retinopathy

5.4 Cataract

5.5 Dry Eye Syndrome

5.6 Macular Degeneration

5.7 Diabetic Macular Edema

5.8 Refractive Issues

5.9 Other Diseases

6 Segmentation of North America Market by Setting

6.1 Market Overview by Setting

6.2 Hospitals

6.3 Clinics

6.4 Homecare Settings

6.5 Ambulatory Surgical Centers (ASCs)

6.6 Other Settings

7 North America Market 2021-2031 by Country

7.1 Overview of North America Market

7.2 U.S.

7.3 Canada

7.4 Mexico

8 Competitive Landscape

8.1 Overview of Key Vendors

8.2 New Product Launch, Partnership, Investment, and M&A

8.3 Company Profiles

For more information about this report visit https://www.researchandmarkets.com/r/8l1l5w